Objectives-To investigate the eVects of lead and cadmium on the metabolic pathway of vitamin D 3 . Methods-Blood and urinary cadmium and urinary total proteins were measured in 59 smelter workers occupationally exposed to lead and cadmium. This study sought to investigate the eVect of exposure to the heavy metals lead and cadmium on the plasma concentrations of vitamin D 3 metabolites and to determine the eVects of dual exposure. The metabolic pathway of vitamin D 3 , cholecalciferol, involves the gut, liver, kidneys, and bones, all of which are aVected by these metals.
This study sought to investigate the eVect of exposure to the heavy metals lead and cadmium on the plasma concentrations of vitamin D 3 metabolites and to determine the eVects of dual exposure. The metabolic pathway of vitamin D 3 , cholecalciferol, involves the gut, liver, kidneys, and bones, all of which are aVected by these metals. 1 2 The liver and kidneys are target organs for lead and cadmium, so that a potential biochemical eVect might be found in the vitamin D 3 pathway to explain the changes in bone metabolism found after exposure to lead or cadmium. [3] [4] [5] [6] Damage caused by cadmium to the renal tubules 7 8 was considered especially relevant to the formation of the more active dihydroxy metabolites, 24R, 25-dihydroxycholecalciferol (24R,25(OH) 2 D 3 ) and 1 , 25-dihydroxycholecalciferol, (1 ,25 (OH) 2 D 3 ).
In the human, vitamin D 3 is obtained either from the diet 9 10 or is metabolised from 7-dehydrocholesterol by the epidermis in the presence of sunlight or ultraviolet light. 11 12 The enzymatic conversion of vitamin D 3 to 25-hydroxycholecalciferol, 25(OH)D 3 , takes place in the liver, 13 whereas the second hydroxylation of 25(OH)D 3 to form the dihydroxy metabolites, 24R,25-(OH) 2 D 3 and 1 ,25(OH) 2 D 3 occurs mainly in the kidney.
14 It has been suggested that this second hydroxylation is catalysed by a single enzyme 15 ; however, earlier studies identified two membrane bound multiple enzyme complexes in the mitochondria of cells in the proximal convoluted and straight tubular sections of the nephron. 16 17 Other sites postulated for this hydroxylation include the placenta 18 and the epidermis, especially in the keratinocytes, 19 which are extremely active in psoriatic patients. 20 Absorption of calcium from the gut is increased by 1 ,25(OH) 2 D 3, 21-23 whereas it has been shown that 24R,25(OH) 2 D 3 does not aVect this regulation of calcium uptake from the small intestine. 24 Both metabolites are implicated in the turnover of calcium in bone, with 1 ,25(OH) 2 D 3 considered more important in the control of osteoclasts, 25 26 and 24R,25(OH) 2 D 3 more eVective on the osteoblasts. 27 Dietary lead intake aVects the absorption of calcium from the gut 28 and interferes with bone formation. 29 30 Calcium and lead compete for binding sites on mucosal proteins in the intestine, 31 although more recent work by these authors suggested that the primary eVect was on the cholecalciferol endocrine system, rather than the interaction of calcium and lead at the intestinal level. 28 In children with increased lead absorption, a reduction in 1 ,25 (OH) 2 D 3 concentrations has been reported, 32 which returned to normal once blood lead decreased to <30 µg/dl (1.4 µmol/l). It has been suggested that chronic cadmium exposure is linked with the subsequent appearance of osteomalacia and osteoporosis. 33 In smelter workers with a known exposure to both lead and cadmium there was a possibility that if the vitamin D 3 metabolic pathway was aVected, this should be apparent in the plasma concentrations of the active dihydroxy metabolites. The eVects of exposure to a combination of lead and cadmium were also investigated. In this study, the plasma concentrations of three metabolites of vitamin D 3 , 25(OH) 2 D 3 , 24R,25(OH) 2 D 3 , and 1 ,25 (OH) 2 D 3 , blood concentrations of lead and cadmium, and urinary concentrations of cadmium and total proteins were measured.
Materials and methods

BLOOD AND URINARY SAMPLES
During their routine health check, male workers in a large non-ferrous metal smelter took part in a survey of the eVects of long term low level cadmium exposure. 34 In the five year follow up study 35 59 of these workers were available for retesting (follow up group). Blood samples from 19 of these participants collected consecutively, (study group), were stored in conditions suitable for analysing vitamin D 3 metabolites. These blood samples were collected into tubes containing lithium heparin anticoagulant, mixed, and stored at 4°C in light proof containers. Samples were divided into two; one batch was stored at −20°C until analysed for lead and cadmium, whereas the other was centrifuged and the plasma separated and stored in glass vials at −20°C, protected from light, until assayed for vitamin D 3 metabolites. The urine samples were stored in acid washed plastic vials at −20°C. These were spot urine samples, not 24 hour collections, thus all urinary calculations are based on concentration rather than excretion rates. Apart from the diYculty of obtaining collections of 24 hour urine from these volunteers, the probability of cadmium contamination was a deciding factor in collecting spot samples. Figure 1 shows the analytical procedures, which were based on the methods developed by Edelstein (personal communication). Extraction methods were based on the procedure described by Lidor et al. 36 Trace amounts of all three tritiated metabolites were added to all samples to monitor the recovery of the metabolites throughout the procedure. Samples were analysed for lead and cadmium with an IL Video 11 spectrophotometer and IL 655 furnace atomiser with Fastac II autosampler, Thermo Electron, Warrington, Cheshire, UK. A single matrix matched calibration curve was used to determine concentrations and all samples were analysed in duplicate with two replicates per sample; reproducibility was <10% CV. Control blood samples for metals were used at two concentrations, lead 15 and 40 µg/dl, and cadmium 4.5 and 57.9 nmol/l, control urine samples for cadmium were used at three concentrations 30, 180, and 410 nmol/l. The laboratory participated in external quality assurance schemes for blood lead and for blood and urinary cadmium. The results obtained were as follows, Blood Lead Proficiency Testing, Centers for Disease Control, Atlanta, Georgia, State Laboratory of Hygiene, all concentrations were within target ranges; UK National External Quality Assessment Scheme (NEQAS) for lead and cadmium in blood, Queen Elizabeth Hospital, Birmingham, the mean running variance index score, (MRVIS) for lead was MRVIS=24, (MRVIS=44 for all participants), for cadmium MRVIS=23 (MRVIS=57 for all participants); trace element quality assessment scheme (TEQAS), Analytical Unit, Robens Institute, University of Surrey, UK, for blood lead and blood and urinary cadmium, all the cumulative scores (CUSUM) were above the acceptable concentration of CUSUM=20, blood lead CUSUM=85.8, blood cadmium CUSUM=71, urinary cadmium CUSUM=36.4. 38 39 in which protein in the urine is bound to an acidified dye reagent (Coomassie brilliant blue (G250) dye). The observed change in absorbance was proportional to the protein concentration and the test was linear up to 150 mg/dl with a sensitivity of 1.1 mg/dl. Assays were carried out at room temperature in glass tubes and all measurements were in duplicate. Saline solution, 0.9%, was used as the reagent blank and extra control standards were prepared with a mixture of human albumin and globulin in a 1:1 ratio. Dye/protein colour was stable for 60 minutes and all samples were read within that time with a Varian Techtron spectrophotometer, series 634, Varian, Walton on Thames, Surrey, KT12 2QF, UK.
CHEMICALS
STATISTICAL ANALYSIS
The statistical package SPSS for Windows was used for all calculations. Frequency distributions were measured for all variables and log transformations used for skew variables. Correlation coeYcients and regression analyses were calculated. The non-parametric Kruskal-Wallis one way analysis of variance (K-W one way ANOVA) was used to measure the relation between 1 ,25(OH) 2 D 3 and cadmium with lead. Table 2 shows a correlation matrix with significance levels for all variables. Figure 2 shows the regression line for log blood cadmium and log urinary cadmium, the regression coeYcients being +0.35 (SE 0.077) and the residual SD (in logs to the base 10) was 0.20, corresponding to a 95% prediction width of 2. (fig 3) , when these were grouped according to the following combination of blood lead and blood or urinary cadmium concentrations: group 1, low Pb/high Cd, blood lead <1.9 µmol/l with urinary cadmium >8 nmol/l or blood cadmium >27 nmol/l; group 2, raised Pb/low Cd, blood lead >1.4 µmol/l with urinary cadmium < 8 nmol or blood cadmium <27 nmol/l; group 3, high Pb/high Cd, blood lead >1.9 µmol/l with urinary cadmium > 8 nmol/l or blood cadmium >27 nmol/l. Figure 4 shows the eVect of urinary cadmium concentrations >8 nmol/l and blood cadmium concentrations >27 nmol/l on plasma 24R,25(OH) 2 D 3 . There is a decrease in the plasma 24R,25(OH) 2 D 3 concentrations as the cadmium concentrations increase.
Results
Discussion
These results suggest that increased blood and urinary cadmium and blood lead cause perturbation of the conversion of 25(OH)D 3 to 24R,25(OH) 2 D 3 and 1 ,25(OH) 2 D 3 . In the presence of cadmium, lead seems to be associated with increased conversion of 25(OH)D 3 to 1 ,25(OH) 2 D 3 . Unlike the eVect in children, 32 in whom the conversion of 25(OH)D 3 to 1 ,25(OH) 2 D 3 may be reduced when the blood lead concentration is >1.4 µmol/l (>30 µg/dl), in these adults the conversion seemed to be enhanced as blood lead concentrations increased. The negative correlation found in children between blood lead and 1 ,25 (OH) 2 D 3 43 was not found in these adults. The membrane bound enzyme complexes that catalyse the formation of 24R,25(OH) 2 termed 25OH-D 3 -24R-hydroxylase (24R-OHase) and OHD 3 -1 -hydroxylase (1 -OHase) respectively. 44 They are found in the mitochondria of the cells lining the proximal convoluted tubules and the straight tubular segments of the nephron. Phosphorylation of an inactive phosphatase is necessary for the activation of the 1 -OHase, which catalyses the formation of 1 ,25(OH) 2 D 3 and a calcium dependant protein kinase converts this enzyme complex to the fully active 24R-OHase. It has been suggested that lead interferes with phosphate linked reactions and that perturbations of calcium mediated processes are an early eVect of lead toxicity at the cellular level. 45 Cadmium induces osteomalacia by a direct action on bone through abnormal calcium homeostasis 46 and has an eVect on bone repair by reduction of alkaline phosphatase activity in osteoblastic cells. 47 Lead is initially accumulated in renal tissue and may be taken up by the renal tubular epithelial cells from the basolateral side by active transport as the free ion. 48 Both the structure and function of mitochondria are very sensitive to lead, which is rapidly taken up by these organelles by an active transport process that may be comparable with the transport process associated with calcium. Granules found in mitochondria exposed to lead are thought to be precipitates of both calcium and lead phosphates. 49 50 Lead may therefore interfere with both calcium and phosphate metabolism and thus aVect enzymatic function in the vitamin D 3 pathway. The kidney matures gradually from infancy and thus these membrane bound enzyme complexes that catalyse the formation of 24R,25(OH) 2 2 D 3 are low in children with raised lead concentrations. Cadmium damage to the renal tubules may aVect the folding, cleavage, and reorientation of the active sites of these enzymes. 44 Therefore cadmium and lead could have a combined eVect on this enzyme complex inhibiting the inactivation of the 1 -OHase and its conversion to partially active 24R-OHase. This would subsequently prevent the formation of fully active 24R-OHase, resulting in raised concentrations of 1 ,25(OH) 2 D 3 and depleted concentrations of 24R,25(OH) 2 D 3 .
Concentrations of lead and cadmium in blood are indicators of present or recent exposure to these metals, whereas the concentrations in urine indicate previous or long term exposure. 42 51 However, a significant correlation has been shown between cadmium concentrations in blood and urine in this study, which suggests that continuous long term exposure to cadmium produces a state of equilibrium. The interrelation between blood and urinary cadmium concentrations and the decrease in 24R,25(OH) 2 D 3 may have appeared after exposure to cadmium of as yet unknown duration. As these workers were still exposed to Figure 3 The eVect of lead and cadmium on plasma 1∝, 25 cadmium and were taking part in a five year follow up study, it is possible to state that they had been continuously exposed to cadmium for at least five years. The preferential incorporation of lead rather than calcium into bone and the osteomalacia and osteoporosis found after cadmium ingestion may be linked with decreased 24R,25(OH) 2 D 3 concentrations, but this remains unproved. Epidemiological and clinical studies in Japan since 1962 have shown that bone is aVected only after very high exposure to cadmium. 6 However, where there is exposure to both lead and cadmium, as in this report, the eVects on bone, mediated through the vitamin D 3 pathway, may possibly be found at lower exposures.
The negative correlation of 25(OH)D 3 with total urinary proteins agrees with that found by Saha, 52 who also found that patients with heavy proteinuria had abnormal regulation of 1 ,25(OH) 2 D 3 and a dependency on 25(OH) D 3 . Chronic renal failure from other causes did not seem to aVect 25(OH)D 3 concentrations. 53 Nogawa et al found that cadmium initially disturbed the hydroxylation of 25(OH)D 3 to 24R,25(OH) 2 D 3 but that at higher blood cadmium concentrations the hydroxylation of 1 ,25(OH) 2 D 3 was aVected, in participants with poor renal function.
54
Conclusions
The highly significant correlation between the cadmium concentrations in blood and urine suggested that continuous long term exposure to cadmium can result in an equilibrium between blood and urinary concentrations. In this situation, it is possible to estimate cadmium blood concentrations from the analysis of spot urine samples. Cadmium and lead have an eVect on vitamin D 3 metabolism at blood and urinary concentrations below those at which there is clinical evidence of toxicity. Cadmium decreased the concentrations of 1 ,25(OH) 2 D 3 and 24R,25(OH) 2 D 3 , whereas cadmium and lead increased the concentrations of 1 ,25(OH) 2 D 3 . Biochemical changes may occur that could have long term health implications. Although many sources of lead and cadmium have been removed, exposure in industrial situations is still possible. The simultaneous exposure to more than one contaminant may lower threshold levels for the appearance of health eVects and this should be taken into account in routine monitoring.
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